Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

February 24, 2025

Primary Completion Date

May 6, 2025

Study Completion Date

May 14, 2025

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

JT002 Nasal spray

200 μg BID, 400 μg BID, 400 μg QD, 800 μg QD, 64 patients per cohort, total 256 patients for treatment 14 days

DRUG

Placebo

Total 64 patients for treatment 14 days

Trial Locations (44)

100069

Beijing Youan Hospital Capital Medical University, Beijing

100191

Peking University Third Hospital, Beijing

110000

Shengjing Hospital Affiliated to China Medical University, Shenyang

112700

Liaoning Provincial Health Industry Group Iron Coal General Hospital, Tieling

150001

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

150081

The People's Hospital of daqing, Daqing

200000

The First Affiliated Hospital of Nanchang University, Nanchang

200031

Eye&Ent Hospital of fudan University, Shanghai

200131

The Second Hospital of Baoding City, Baoding

201399

Shanghai Pudong Hospital, Fudan University Affiliated Pudong Medical Center, Shanghai

255000

Zibo central hospital, Zibo

300121

Tianjin People's Hospital, Tianjin

330006

The First Affiliated Hospital of Nanchang University, Nanchang

The Second Affiliated Hospital of Nanchang University, Nanchang

350001

Fujian Medical University Union Hospital, Fuzhou

350004

The First Affiliated Hospital of Fujian Medical University, Fuzhou

430014

Wuhan Central Hospital, Wuhan

430060

Renmin Hospital of Wuhan University, Wuhan

434000

Jingzhou Central Hospital (Jingzhou Hospital affiliated to Yangtze University), Jingzhou

450000

Zhengzhou Central Hospital, Zhengzhou

518000

Shenzhen Nanshan District People's Hospital, Shenzhen

Shenzhen University General Hospital, Shenzhen

617000

Panzhihua Hospital of Integrated Traditional Chinese and Western Medicine, Panzhihua

710000

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi’an

The Second Affiliated Hospital of Xi 'an Jiaotong University, Xi’an

710016

Xi'an DaXing Hospital, Xi’an

710075

Xi'an High tech Hospital, Xi’an

733000

Wuwei People's Hospital, Wuwei

750000

People's Hospital of Ningxia Hui Autonomous Region, Yinchuan

The First People's Hospital of Yinchuan, Yinchuan

830054

The First Affiliated Hospital of Xinjiang Medical Universit, Ürümqi

061014

Cangzhou Central Hosptial, Cangzhou

065000

Hebei Retro China Central Hosptial, Hebei

050000

Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang

050051

The Third Hospital of Hebei Medical University, Shijiazhuang

075061

The First Affiliated Hospital of Hebei North University, Zhangjiakou

010030

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

014010

BaogangHospital of InnerMongolia, Baotou

024099

Chifeng municipal hospital, Chifeng

046000

Heping hospital affiliated to Changzhi medical college, Changzhi

030001

Second hospital of Shanxi Medical University, Taiyuan

030012

First Hospital Of Shanxi Medical University, Taiyuan

030032

Shanxi Bethune hospital, Taiyuan

044000

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Shanghai JunTop Biosciences Co., LTD

INDUSTRY

NCT06861101 - Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults | Biotech Hunter | Biotech Hunter